TruScreen Group Limited (NZE:TRU)

Market Cap	16.11M +26.7%
Revenue (ttm)	2.82M +36.1%
Net Income	-2.25M
EPS	-0.00
Shares Out	1.01B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,909
Open	0.0160
Previous Close	0.0160
Day's Range	0.0160 - 0.0160
52-Week Range	0.0150 - 0.0250
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2026

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: TRU

Financial Performance

In fiscal year 2026, TruScreen Group's revenue was 2.82 million, an increase of 36.13% compared to the previous year's 2.07 million. Losses were -2.25 million, 0.41% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 14, 2026

Data Sources Report a data error